Elhízás: vizsgálatok itt: Japán
36 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 3. fázisNot yet taking people in JapánA Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
- Where
- Chiba-shi, Chiba, Fuchu-shi,Tokyo, Fukuoka, Himeji-shi, Hyogo, Hyōgo, Kanagawa, Kumamoto-shi, Kumamoto, Kyoto-shi, Kyoto, Matsumoto-shi, Nagano, Matsuyama-shi, Ehime, Morioka-shi, Iwate, Ono-shi Hyogo, Osaka-shi Osaka, Osaka-shi, Osaka, Ota-shi, Gunma, Suginami-ku, Tokyo, Takamatsu-shi, Kagawa, Tokorozawa-shi,Saitama, Tokyo, Toshima-ku,Tokyo, Wakayama-shi, Wakayama, Yao City, Osaka
- Életkor
- 45 év to 64 év
- People
- 8500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07861100 · EU 2026-525182-53-00 - 3. fázisTaking peopleExtension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Where
- Aki-gun, Kashiwara-shi, Kitakyusyu-shi, Kumamoto, Matsuyama, Meguro-ku, Mitaka-shi, Mito, Naka, Shizuoka, Tsuchiura-shi
- Életkor
- 18 év to 99 év
- People
- 950 worldwide
- Run by
- Amgen
See details and how to joinNCT07684144 · EU 2025-524788-19-00 - 3. fázisTaking peopleExtension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Where
- Chiyoda-ku, Chuo-ku, Hachioji-shi, Minato-ku, Shinjuku-ku, Suginami-ku, Yokohama
- Életkor
- 18 év to 99 év
- People
- 3200 worldwide
- Run by
- Amgen
See details and how to joinNCT07684235 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Where
- Adachi-ku, Chūōku, Fukuoka, Minato, Mitaka, Suita-shi, Tokyo
- Életkor
- 18 év and over
- People
- 1980 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07321886 · EU 2025-523657-34-00 - No phaseCsak meghívásosCities for Better Health Childhood Obesity Prevention Initiative
- Where
- Chiba
- Életkor
- 6 év to 13 év
- People
- 36 000 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06855563 - 3. fázisTaking peopleAMAZE 10: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People in Japan With Excess Body Weight Lose Weight
- Where
- Aichi, Bunkyo-ku, Tokyo, Chiba, Chiba-shi, Chiba, Chigasaki-shi, Chiyoda-ku, Tokyo, Chuo-ku, Tokyo, Fukuoka-shi, Fukuoka, Ibaraki, Kagawa, Kamakura-shi, Kanagawa, Kanagawa, Kawasaki-shi, Kitakyushu-shi, Fukuoka, Koriyama-shi, Fukushima, Kyoto-shi, Kyoto, Osaka, Osaka-shi, Osaka, Sapporo, Suita-shi, Tokyo, Yamato-shi, Yao City, Osaka
- Életkor
- 18 év and over
- People
- 400
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07822061 - 3. fázisNot yet taking people in JapánAMAZE 13: A Research Study Investigating How Well the Medicine Zenagamtide Helps People in Asia With Excess Body Weight Lose Weight
- Where
- Sakai-shi, Osaka, Shinjuku-ku, Tokyo, Suita-shi, Tokyo
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07668401 - 3. fázisTaking peopleA Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Where
- Bunkyo-ku, Tokyo, Chiba-shi,Chiba, Chikushino-shi, Fukuoka, Fuchu-shi,Tokyo, Fukuoka-shi, Fukuoka, Higashiosaka-shi, Osaka, Himeji-shi, Hyogo, Hyōgo, Ibaraki, Kanagawa, Kasugai-shi, Aichi, Kofu-shi, Yamanashi, Kyoto-shi, Kyoto, Maebashi-shi, Gunma, Matsumoto-shi, Nagano, Miura-gun, Kanagawa, Morioka-shi, Iwate, Nagasaki, Osaka, Osaka-Shi, Osaka, Ota-shi, Gunma, Sapporo-shi, Hokkaido, Shinjuku-ku, Tokyo, Shizuoka, Takamatsu-shi, Kagawa, Tokyo, Tomakomai-Shi, Hokkaido, Toshima-ku,Tokyo, Uwajima-shi, Wakayama-shi, Wakayama, Yokohama-shi,Kanagawa
- Életkor
- 18 év and over
- People
- 5610 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07567001 · EU 2025-523717-29-00 - 1. fázisNot yet taking people in JapánA Study of Macupatide (LY3532226) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Where
- Fukuoka, Sumida-ku, Toshima City
- Életkor
- 18 év to 65 év
- People
- 60
- Run by
- Eli Lilly and Company
See details and how to joinNCT07765511 - 2. fázisTaking peopleA Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
- Where
- Aichi, Ibaraki, Kanagawa, Kita-ku, Tokyo, Koriyama-shi, Fukushima, Saitama, Sendai-shi, Miyagi, Siga, Tokyo
- Életkor
- 18 év and over
- People
- 465 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06717698 · EU 2024-510846-15-00 - No phaseTaking peopleOsaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2
- Where
- Sakai
- Életkor
- 20 év and over
- People
- 2000
- Run by
- Osaka Metropolitan University
See details and how to joinNCT06694012